Cytometry analysis for COVID-19 drug development

26.1 - Noyau

Service description

Flow cytometry for the development of anti-coronavirus drugs can be used for several needs, including studies of immunological markers and the sorting of virus-infected cells.

Mass cytometry can be used to multiply the number of targets analyzed.

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert

Get started with your COVID-19 cytometry analysis request

Please answer the fields below to be contacted by our team of scientists